The leader of the long-running study said that the drugs did not improve mental health in children with gender distress and that the finding might be weaponized by opponents of the care.
Related Posts
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now,…
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
Bristol Myers Squibb, the global pharmaceutical giant, said on Friday that it would acquire Karuna Therapeutics, which makes drugs to…
Did Your Baby Spend Time in the NICU? Tell Us About It.
Across the country, neonatal intensive care units provide critical care to seriously ill babies. That care can be lifesaving but…